Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Publications

2022 Heading link

  • 25th January, 2022

    XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer

    Authors:
    Daniel R. Principe, Rui Xiong, Yangfeng Li, Thao N. D. Pham, Suneel D. Kamath, Oleksii Dubrovskyi, Kiira Ratia, Fei Huang, Jiong Zhao, Zhengnan Shen, Dinesh Thummuri, Zhou Daohong, Patrick W. Underwood, Jose Trevino, Hidayatullah G. Munshi, Gregory R. J. Thatcher, and Ajay Rana

    Journal:
    PNAS

    Citation Link

  • 24th January, 2022

    Structure–Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors

    Authors:
    Andrey A. Poloznikov, Sergey V. Nikulin, Dmitry M. Hushpulian, Anna Yu. Khristichenko, Andrey I. Osipyants, Andrey F. Asachenko, Olga V. Shurupova, Svyatoslav S. Savin, Sue H. Lee, Irina N. Gaisina, Gregory R. J. Thatcher, Anthony Narciso, Eric P. Chang, Sergey V. Kazakov, Nancy Krucher, Vladimir I. Tishkov, Bobby Thomas, Irina G. Gazaryan

    Journal:
    Antioxidants

    Citation Link

2021 Heading link

2020 Heading link

2019 Heading link

2018 Heading link

2017 Heading link

2016 Heading link